Emtricitabine and Tenofovir Tablet
Generic Name |
Emtricitabine and Tenofovir |
---|---|
Strength |
200 mg +300 mg |
Form |
Tablet |
Packaging |
1 X 10 Tablets |
Therapeutic use |
Anti Viral, HIV Care |
Manufacturing Period |
30 to 45 Days |
Available Composition of
Name | Strength | Therapeutic use | View More |
---|---|---|---|
Lamivudine and Tenofovir Tablet | 300 mg + 300 mg | AIDS, hepatitis B virus (HBV) infection, HIV Care | |
Tenofovir Lamivudine and Efavirenz Tablet | 300 mg + 300 mg + 600 mg | HIV Care | |
Tenofovir Tablet | 300 mg | HIV Care, Hepatitis Care | |
Emtricitabine, Tenofovir and Efavirenz Tablet | 200 mg + 300 mg + 600 mg | Anti Viral, HIV Care | |
Emtricitabine and Tenofovir Tablet | 200 mg +300 mg | Anti Viral, HIV Care | |
Emtricitabine and Tenofovir Alafenamide Tablet | 200 mg + 25 mg | Anti Viral, HIV Care |
Product Description For Emtricitabine and Tenofovir Tablet
products details and uses
Emtricitabine and Tenofovir Tablet Exporter, Manufacturer and Global Exporter in India
Emtricitabine and Tenofovir Tablet Exporter, as a trusted manufacturers in India ensure that the medicine complies with stringent international quality standards and is supplied to global healthcare markets at competitive prices. Emtricitabine and Tenofovir Tablet is a widely prescribed antiretroviral medicine used for the effective management of HIV-1 infection in adults and adolescents. It belongs to the class of medicines called nucleoside reverse transcriptase inhibitors (NRTIs). By combining Emtricitabine (200 mg) with Tenofovir disoproxil fumarate (300 mg), this dual formulation helps reduce the viral load in the body, increases the immune system response, and lowers the risk of HIV-related complications. The fixed-dose combination is also recommended as part of a pre-exposure prophylaxis (PrEP) regimen to minimize the risk of acquiring HIV in high-risk individuals.
Uses of Emtricitabine and Tenofovir Tablet
-
Treatment of HIV infection – When taken with other antiretroviral medicines, it helps control HIV-1 infection by decreasing viral replication.
-
Prevention of HIV (PrEP) – It is used in HIV-negative adults and adolescents at substantial risk, reducing the likelihood of acquiring HIV through sexual contact.
-
Improves immunity – By lowering viral activity, the combination helps CD4 cells recover and enhances overall immunity.
-
Delays complications – Effective use reduces the chances of opportunistic infections and progression to AIDS.
Healthcare professionals prescribe the exact dose depending on the patient’s weight, viral load, and treatment history.
Precautions for Emtricitabine and Tenofovir Tablet
-
Medical history check – Patients with kidney disease, liver problems (including hepatitis B), or bone mineral loss must inform their doctor before beginning therapy.
-
Regular monitoring – Periodic liver function, kidney function, and bone density tests are often recommended to ensure safety.
-
Adherence is key – Skipping doses may increase viral resistance and reduce effectiveness.
-
Pregnancy and breastfeeding – The medicine should only be used during pregnancy or lactation if advised by a doctor, as it may pass into breast milk.
-
Drug interactions – Concomitant use with nephrotoxic drugs, antivirals, or certain antibiotics should be closely monitored.
As a reliable Emtricitabine and Tenofovir Tablet Exporter, Indian pharmaceutical companies highlight proper storage (below 30°C, away from moisture and sunlight) to maintain stability and efficacy.
Possible Side Effects of Emtricitabine and Tenofovir Tablet
Like all medicines, this combination may cause mild to moderate side effects in some patients. Commonly reported include:
-
Headache, dizziness, and tiredness
-
Nausea, diarrhea, and abdominal discomfort
-
Skin discoloration or rash
-
Trouble sleeping or mood changes
Less common but more serious side effects may include:
-
Kidney problems such as reduced urine output or elevated creatinine levels
-
Lactic acidosis (rare but serious)
-
Hepatic complications including hepatitis B flare-ups after discontinuation
-
Bone mineral density loss leading to osteoporosis in long-term use
Patients are advised to seek immediate medical attention if they notice unusual symptoms like persistent nausea, yellowing of skin/eyes, difficulty breathing, or muscle weakness.
Why Choose an Indian Emtricitabine and Tenofovir Tablet Exporter?
India is a leading hub for generic antiretroviral drug manufacturing. A trusted Emtricitabine and Tenofovir Tablet Exporter from India ensures:
-
WHO-GMP and ISO certified manufacturing facilities
-
Affordable pricing without compromising on global quality standards
-
Wide distribution network for timely availability across international markets
-
Compliance with stringent packaging and labeling norms for safe global shipping
Conclusion
Emtricitabine and Tenofovir Tablet plays a vital role in the fight against HIV by combining two potent NRTIs in a single convenient dose. It is effective both as treatment and prevention, ensuring better health outcomes for patients and high-risk individuals. With India’s robust pharmaceutical industry, choosing a reputed Emtricitabine and Tenofovir Tablet Exporter guarantees access to quality-assured medicines that meet the needs of healthcare providers worldwide.
Global Distribution Network
With a strong logistics and compliance framework, we successfully export Emtricitabine and Tenofovir Tablet to a broad range of international markets, including: Venezuela, Brazil, Cambodia, Philippines, Nigeria, Myanmar, Thailand, Singapore, Russia, Kyrgyzstan, Tajikistan, Kenya, Zimbabwe, Somalia, Djibouti, Belarus, Macedonian, And Turkey.